ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

11,781Medicare Part D Prescriptions Filled, Including Refills
$475K Total Retail Price of All Prescriptions
289 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LEVOTHYROXINE SODIUM 655 584
FUROSEMIDE 483 470
POTASSIUM CHLORIDE 377 350
HYDROCODONE-ACETAMINOPHEN 373 359 S3
MELOXICAM 334 324
PRAVASTATIN SODIUM 275 251
LISINOPRIL 246 234
OMEPRAZOLE 228 174
METFORMIN HCL 205 202
WARFARIN SODIUM 200 197
SIMVASTATIN 188 159
LOSARTAN POTASSIUM 175 169
RANITIDINE HCL 168 144
DIGOXIN 167 162
CITALOPRAM HBR 161 158
METOPROLOL TARTRATE 160 138
DOXAZOSIN MESYLATE 156 141
LOVASTATIN 156 154
METOPROLOL SUCCINATE 153 153
SERTRALINE HCL 148 133
GABAPENTIN 143 131
LANTUS 139 118
ALLOPURINOL 137 126
ATENOLOL 132 115
DONEPEZIL HCL 130 130
SPIRONOLACTONE 125 125
TAMSULOSIN HCL 124 100
GLIPIZIDE 115 112
CARBIDOPA-LEVODOPA 113 113
NAMENDA 107 107
MIRTAZAPINE 106 106
PREDNISONE 105 101
CLOPIDOGREL 97 86
SUCRALFATE 94 77
CARVEDILOL 93 83
ATORVASTATIN CALCIUM 89 82
GLIPIZIDE ER 86 86
CEPHALEXIN 83 79
SULINDAC 81 81
AGGRENOX 81 81
TRAMADOL HCL 76 76
FLUTICASONE PROPIONATE 73 69
FINASTERIDE 70 70
TRIAMCINOLONE ACETONIDE 70 68
NOVOLOG 69 53
VOLTAREN 68 68
AMLODIPINE BESYLATE 68 56
TRIAMTERENE-HCTZ 67 67
CYMBALTA 67 63
ESCITALOPRAM OXALATE 66 48
LOSARTAN-HYDROCHLOROTHIAZIDE 63 63
PLAVIX 61 55
TRAZODONE HCL 57 52
DILTIAZEM 24HR ER 56 43
METOCLOPRAMIDE HCL 54 30
POLYETHYLENE GLYCOL 3350 54 54
KRISTALOSE 52 52
FAMOTIDINE 50 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.